Leaders of the Senate Finance Committee on Friday unveiled an updated version of their bipartisan drug pricing bill, though it’s unclear if the changes will appease skeptical Republican senators.
The renewed push for Republican support by Chairman Charles E. Grassley of Iowa and the committee’s ranking Democrat, Ron Wyden of Oregon, comes ahead of a planned House vote next week on Democrats’ signature drug price negotiation bill.